Molecular epidemiology and virulence of Escherichia coli O16: H5-ST131: Comparison with H30 and H30-Rx subclones of O25b: H4-ST131

International Journal of Medical Microbiology

Volumn 304, Issue 8, 2014, Pages 1247-1257

  Dahbi, Ghizlane ^a   Mora, Azucena ^a   Mamani, Rosalia ^a   López, Cecilia ^a   Alonso, María Pilar ^b   Marzoa, Juan ^a   Blanco, Miguel ^a   Herrera, Alexandra ^a   Viso, Susana ^a   García Garrote, Fernando ^b   Tchesnokova, Veronika ^c   Billig, Mariya ^c   de la Cruz, Fernando ^d   de Toro, María ^d   González López, Juan José ^e,f   Prats, Guillermo ^e,f   Chaves, Fernando ^g   Martínez Martínez, Luis ^h   López Cerezo, Lorena ⁱ   Denamur, Erick ^j,k   Blanco, Jorge ^a   more..

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL UNIVERSITARIO LUCUS AUGUSTI   (Spain)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^j UNIVERSITÉ PARIS DIDEROT   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

E. coli; ExPEC; H30 and H30 Rx subclones; O16:H5; O25b:H4; ST131 clonal group

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; SULFAMETHOXAZOLE; TOBRAMYCIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; FIMH22 ALLELE; FIMH30 ALLELE; FIMH41 ALLELE; GENETIC VARIABILITY; HOSPITAL INFECTION; MENINGITIS; MOLECULAR EPIDEMIOLOGY; MOUSE; NONHUMAN; PHYLOGENETIC TREE; SEPSIS; SEQUENCE ANALYSIS; SEROTYPE; URINARY TRACT INFECTION;

EID: 84940164435     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.10.002     Document Type: Article

References (44)

1. Banerjee R., Johnston B., Lohse C., Chattopadhyay S., Tchesnokova V., Sokurenko E.V., Johnson J.R. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob. Agents Chemother. 2013, 57:5912-5917.
2. Banerjee R., Robicsek A., Kuskowski M.A., Porter S., Johnston B.D., Sokurenko E., Tchesnokova V., Price L.B., Johnson J.R. Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob. Agents Chemother. 2013, 57:6385-6388.
3. Banerjee R., Johnson J.R. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob. Agents Chemother. 2014, 58:4997-5004.
4. Blanc V., Leflon-Guibout V., Blanco J., Haenni M., Madec J.Y., Rafignon G., Bruno P., Mora A., Lopez C., Dahbi G., Dunais B., Anastay M., Branger C., Moreau R., Pradier C., Nicolas-Chanoine M.H. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J. Antimicrob. Chemother. 2014, 69:1231-1237.
5. Blanco M., Alonso M.P., Nicolas-Chanoine M.H., Dahbi G., Mora A., Blanco J.E., López C., Cortés P., Llagostera M., Leflon-Guibout V., Puentes B., Mamani R., Herrera A., Coira M.A., García-Garrote F., Pita J.M., Blanco J. Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2009, 63:1135-1141.
6. Blanco J., Mora A., Mamani R., López C., Blanco M., Dahbi G., Herrera A., Blanco J.E., Alonso M.P., García-Garrote F., Chaves F., Orellana M.Á., Martínez-Martínez L., Calvo J., Prats G., Larrosa M.N., González-López J.J., López-Cerero L., Rodríguez-Baño J., Pascual A. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 2011, 66:2011-2021.
7. Blanco J., Mora A., Mamani R., López C., Blanco M., Dahbi G., Herrera A., Marzoa J., Fernández V., de la Cruz F., Martínez-Martínez L., Alonso M.P., Nicolas-Chanoine M.H., Johnson J.R., Johnston B., López-Cerero L., Pascual A., Rodríguez-Baño J. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J. Clin. Microbiol. 2013, 51:3358-3367. Spanish Group for Nosocomial Infections (GEIH).
8. Brisse S., Diancourt L., Laouénan C., Vigan M., Caro V., Arlet G., Drieux L., Leflon-Guibout V., Mentré F., Jarlier V., Nicolas-Chanoine M.H. Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J. Clin. Microbiol. 2012, 50:2974-2981. Coli β Study Group.
9. Buckles E.L., Wang X., Lane M.C., Lockatell C.V., Johnson D.E., Rasko D.A., Mobley H.L., Donnenberg M.S. Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J. Infect. Dis. 2009, 199:1689-1697.
10. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement M100-S19 2010, CLSI, Wayne, PA 19087, USA.
11. Coelho A., Mora A., Mamani R., López C., González-López J.J., Larrosa M.N., Quintero-Zarate J.N., Dahbi G., Herrera A., Blanco J.E., Blanco M., Alonso M.P., Prats G., Blanco J. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 2011, 66:517-526.
12. Colpan A., Johnston B., Porter S., Clabots C., Anway R., Thao L., Kuskowski M.A., Tchesnokova V., Sokurenko E.V., Johnson J.R. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin. Infect. Dis. 2013, 57:1256-1265. VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators.
13. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Cantón R., Nordmann P. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 2008, 14:195-200.
14. Dahbi G., Mora A., López C., Alonso M.P., Mamani R., Marzoa J., Coira A., García-Garrote F., Pita J.M., Velasco D., Herrera A., Viso S., Blanco J.E., Blanco M., Blanco J. Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases. Int. J. Antimicrob. Agents 2013, 42:347-351.
15. Horner C., Fawley W., Morris K., Parnell P., Denton M., Wilcox M. Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12). J. Antimicrob. Chemother. 2014, 69:91-100.
16. Johnson J.R., Murray A.C., Gajewski A., Sullivan M., Snippes P., Kuskowski M.A., Smith K.E. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 2003, 47:2161-2168.
17. Johnson J.R., Clermont O., Menard M., Kuskowski M.A., Picard B., Denamur E. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J. Infect. Dis. 2006, 194:1141-1150.
18. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 2009, 53:2733-2739.
19. Johnson J.R., Urban C., Weissman S.J., Jorgensen J.H., Lewis J.S., Hansen G., Edelstein P.H., Robicsek A., Cleary T., Adachi J., Paterson D., Quinn J., Hanson N.D., Johnston B.D., Clabots C., Kuskowski M.A. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 2012, 56:2364-2370. AMERECUS Investigators.
20. Johnson J.R., Tchesnokova V., Johnston B., Clabots C., Roberts P.L., Billig M., Riddell K., Rogers P., Qin X., Butler-Wu S., Price L.B., Aziz M., Nicolas-Chanoine M.H., Debroy C., Robicsek A., Hansen G., Urban C., Platell J., Trott D.J., Zhanel G., Weissman S.J., Cookson B.T., Fang F.C., Limaye A.P., Scholes D., Chattopadhyay S., Hooper D.C., Sokurenko E.V. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 2013, 207:919-928.
21. Johnson J.R., Clermont O., Johnston B., Clabots C., Tchesnokova V., Sokurenko E., Junka A.F., Maczynska B., Denamur E. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J. Clin. Microbiol. 2014, 52:1358-1365.
22. Kudinha T., Johnson J.R., Andrew S.D., Kong F., Anderson P., Gilbert G.L. Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J. Clin. Microbiol. 2013, 51:3270-3276.
23. Kudinha T., Johnson J.R., Andrew S.D., Kong F., Anderson P., Gilbert G.L. Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls. Clin. Microbiol. Infect. 2013, 19:E173-E180.
24. Leflon-Guibout V., Jurand C., Bonacorsi S., Espinasse F., Guelfi M.C., Duportail F., Heym B., Bingen E., Nicolas-Chanoine M.H. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob. Agents Chemother. 2004, 48:3736-3742.
25. Leflon-Guibout V., Blanco J., Amaqdouf K., Mora A., Guize L., Nicolas-Chanoine M.H. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 2008, 46:3900-3905.
26. Matsumura Y., Yamamoto M., Nagao M., Hotta G., Matsushima A., Ito Y., Takakura S., Ichiyama S. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan. J. Antimicrob. Chemother. 2012, 67:2612-2620. Kyoto-Shiga Clinical Microbiology Study Group.
27. Matsumura Y., Yamamoto M., Nagao M., Ito Y., Takakura S., Ichiyama S. Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups. Antimicrob. Agents Chemother. 2013, 57:4736-4742. Kyoto-Shiga Clinical Microbiology Study Group.
28. Mora A., Herrera A., Mamani R., López C., Alonso M.P., Blanco J.E., Blanco M., Dahbi G., García-Garrote F., Pita J.M., Coira A., Bernárdez M.I., Blanco J. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl. Environ. Microbiol. 2010, 76:6991-6997.
29. Mora A., Blanco M., López C., Mamani R., Blanco J.E., Alonso M.P., García-Garrote F., Dahbi G., Herrera A., Fernández A., Fernández B., Agulla A., Bou G., Blanco J. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int. J. Antimicrob. Agents 2011, 37:16-21.
30. Mora A., Dahbi G., López C., Mamani R., Marzoa J., Dion S., Picard B., Blanco M., Alonso M.P., Denamur E., Blanco J. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLOS ONE 2014, 9(1):e87025.
31. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., Park Y.J., Lavigne J.P., Pitout J., Johnson J.R. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008, 61:273-281.
32. Nicolas-Chanoine M.H., Bertrand X., Madec J.Y. Escherichia coli ST131, an intriguing clonal group. Clin. Microbiol. Rev. 2014, 27:543-574.
33. Olesen B., Hansen D.S., Nilsson F., Frimodt-Møller J., Leihof R.F., Struve C., Scheutz F., Johnston B., Krogfelt K.A., Johnson J.R. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J. Clin. Microbiol. 2013, 51:1779-1785.
34. Paul S., Linardopoulou E.V., Billig M., Tchesnokova V., Price L.B., Johnson J.R., Chattopadhyay S., Sokurenko E.V. Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli. J. Bacteriol. 2013, 195:231-242.
35. Peirano G., Pitout J.D. Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a Canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage. Antimicrob. Agents Chemother. 2014, 58:2699-2703.
36. Peirano G., van der Bij A.K., Freeman J.L., Poirel L., Nordmann P., Costello M., Tchesnokova V.L., Pitout J.D. Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage. Antimicrob. Agents Chemother. 2014, 58:3762-3767.
37. Petty N.K., Ben Zakour N.L., Stanton-Cook M., Skippington E., Totsika M., Forde B.M., Phan M.D., Gomes Moriel D., Peters K.M., Davies M., Rogers B.A., Dougan G., Rodriguez-Baño J., Pascual A., Pitout J.D., Upton M., Paterson D.L., Walsh T.R., Schembri M.A., Beatson S.A. Global dissemination of a multidrug resistant Escherichia coli clone. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:5694-5699.
38. Picard B., Garcia J.S., Gouriou S., Duriez P., Brahimi N., Bingen E., Elion J., Denamur E. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 1999, 67:546-553.
39. Platell J.L., Cobbold R.N., Johnson J.R., Heisig A., Heisig P., Clabots C., Kuskowski M.A., Trott D.J. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob. Agents Chemother. 2011, 55:3782-3787.
40. Price L.B., Johnson J.R., Aziz M., Clabots C., Johnston B., Tchesnokova V., Nordstrom L., Billig M., Chattopadhyay S., Stegger M., Andersen P.S., Pearson T., Riddell K., Rogers P., Scholes D., Kahl B., Keim P., Sokurenko E.V. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 2013, 4:e00377-e413.
41. Sarkar S., Ulett G.C., Totsika M., Phan M.D., Schembri M.A. Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli. PLOS ONE 2014, 9(4):e94786.
42. Tchesnokova V., Billig M., Chattopadhyay S., Linardopoulou E., Aprikian P., Roberts P.L., Skrivankova V., Johnston B., Gileva A., Igusheva I., Toland A., Riddell K., Rogers P., Qin X., Butler-Wu S., Cookson B.T., Fang F.C., Kahl B., Price L.B., Weissman S.J., Limaye A., Scholes D., Johnson J.R., Sokurenko E.V. Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J. Clin. Microbiol. 2013, 51:2991-2999.
43. Weissman S.J., Johnson J.R., Tchesnokova V., Billig M., Dykhuizen D., Riddell K., Rogers P., Qin X., Butler-Wu S., Cookson B.T., Fang F.C., Scholes D., Chattopadhyay S., Sokurenko E. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl. Environ. Microbiol. 2012, 78:1353-1360.
44. Woodford N., Ward M.E., Kaufmann M.E., Turton J., Fagan E.J., James D., Johnson A.P., Pike R., Warner M., Cheasty T., Pearson A., Harry S., Leach J.B., Loughrey A., Lowes J.A., Warren R.E., Livermore D.M. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J. Antimicrob. Chemother. 2004, 54:735-743.